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1. Introduction 
Parkinson Disease affects 4 million people worldwide and it is the second most common 
neurological disorder after Alzheimer disease (Huse et al. 2005). It occurs in 1% of the 
population over the age of 60 years (Adams et al. 1997). The annual incidence of Parkinson’s 
disease is 20.5 per 100,000 (Rajput et al. 1984) and can result in numerous symptoms 
including tremor, muscular rigidity and abnormalities of gait, posture and facial expression. 
Despite optimal pharmacological treatment, progression of Parkinson’s disease normally 
results in a decline in general mobility and ability to ambulate safely.  
Rigidity secondary to Parkinson’s Disease often aggravates joint pain from osteoarthritis 
(Adams et al. 1997). The outcome of joint arthroplasty in these patients is effective in 
relieving pain, but the overall functional results have been found to be variable (Oni et al. 
1985; Vince et al. 1989; Duffy et al. 1996; Koch et al. 1997; Weber et al. 2002; Shah et al. 2005; 
Kryzak et al. 2009; Kryzak et al. 2010). A report from the Scottish joint registry has found an 
annual prevalence of Parkinson’s disease of 5% to 8% in patients undergoing total hip 
arthroplasty (Meek et al. 2006). Optimal management of the disease before, during and after 
surgery is a challenge due to the neurological disturbances in Parkinson’s disease including 
tremor, rigidity, contractures and gait abnormalities. 
We will firstly provide an overview of the difficulties faced when planning surgery in 
patients with Parkinson’s disease before discussing specific pre-, intra- and post-operative 
measures that should be taken. Finally we will provide an overview of the evidence 
available for arthroplasty in Parkinson’s disease specific to the three major joints replaced – 
hip, knee and shoulder. 
2. Parkinson’s disease and surgery 
Patients with Parkinson’s disease usually suffer from rigidity, contractures, tremor and gait 
abnormalities. People with Parkinson’s disease who undergo surgery have longer hospital 
stays and increased mortality (Pepper et al. 1999). Preoperative fasting regimes can 
unnecessarily result in reduced or missed administration of dopaminergic medications and 
subsequent serious complications (Reed et al. 1992). Patients with mild Parkinson’s disease 
are able to tolerate the fasting period but those patients with advanced Parkinson’s disease, 
who are under high doses of levodopa are susceptible to the condition Neuroleptic 
Malignant Syndrome with associated fever, confusion, raised concentration of muscle 
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enzymes and even death (Ueda et al. 1999). The disease itself predisposes these patients to 
increased risk of aspiration pneumonia and urinary tract infection compared to patients 
without the disease (Pepper et al. 1999).  
Discharge from hospital after surgery is more difficult in those with Parkinson’s disease. 
Patients are more likely to suffer from intra – operative and post-operative complication 
including falls and fractures. A longer duration of hospital stay than in patient without 
Parkinson’s disease can be anticipated and appropriate planning is necessary (Mueller et al. 
2009). Planning consists of medical and surgical optimisation and also appropriate 
consideration to prehabilitation, rehabilitation and convalescent requirements. 
2.1 Pre – operative management 
2.1.1 Pharmacologic management 
Patients with Parkinson’s disease require advance planning, appropriate medication and 
specialist neurological advice for optimisation of pharmacological management of the disease 
before, during and after surgery (Brennan et al. 2010). Ideally these patients are screened at the 
pre – assessment clinic, and advice should be sought from a neurologist or geriatrician. The 
neurologist can give advice about the patient treatment regimen for the period around the 
operation and to consider any additional measures required. Brennan and Genever have 
reported that oral medications should be continued until time of anaesthetic induction and 
that patients with Parkinson’s disease are ideally placed at the start of the operating list. This 
facilitates greater predictability over the time of fasting and surgery.  
Alternative Parkinson’s drugs such as apomorphine and rotigontine can be used in the post-
operative period, when post-operative ileus or delayed gastric emptying can be anticipated. 
Apomorphine is a potent dopamine agonist which is delivered subcutaneously, but can 
cause severe emesis and need the concomitant use of an anti-emetic such as domperidon. 
Rotigontine is delivered transdermally; it has ease of use and tolerability but may not 
provide adequate treatment in patients with severe Parkinson’s disease (Brennan et al. 
2010). 
Parkinsonian medication should not be withheld prior to surgery. Although some can 
tolerate missed doses, there are reports of Neuroleptic Malignant Syndrome in cases where 
the regular dose has been omitted (Ueda et al. 1999). Mason et al have provided a detailed 
list of pre-anaesthetic assessments that should be carried out prior to surgery (Mason et al. 
1996). This list details a number of features to look for by system and appropriate 
investigations (Table 1, page 511).  
Respiratory complications are possible as a significant number of patients with Parkinson’s 
Disease have an obstructive picture on pulmonary function testing (Neu et al. 1967). 
Orthostatic hypotension is a potential problem and agents that cause or contribute to 
peripheral vasodilatation can exacerbate this. Hypovolaemia secondary to surgical blood 
loss needs to be attended to as this can clearly contribute to lower blood pressure and risk of 
subsequent fall. Administration of medications such as tricyclic anti-depressants may also 
contribute to a fall in blood pressure and should be used with caution in this patient 
population (Nicholson et al. 2002).  
2.1.2 Bone mineral density 
Several studies have shown that patient with Parkinson’s disease have decreased bone 
mineral density (BMD) and are prone to vitamin D deficiency when compared to the general 
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System Assessment by history Tests 
   
Head and neck Pharyngeal muscle dysfunction 
Dysphagia 
Sialorrhoea 
Blepharospasm 
 
Respiratory Respiratory impairment from rigidity, 
bradykinesia or uncoordinated 
involuntary movement of the respiratory 
muscles 
Chest radiograph 
Pulmonary function tests 
Arterial blood gases 
Cardiovascular  Orthostatic hypotension 
Cardiac arrhythmias 
Hypertension 
Autonomic dysfunction 
ECG 
Gastrointestinal Weight loss 
Poor nutrition 
Susceptibility to  reflux 
Serum albumin/transferrin 
Skin test allergy 
Urological  Difficulty in micturition   
   
Endocrine  Abnormal glucose metabolism (selegiline) Blood glucose concentration 
Musculoskeletal  Muscle rigidity   
Central Nervous System  Muscle rigidity 
Akinesia 
Tremor 
Confusion 
Depression 
Hallucinations 
Speech impairment  
 
   
   
Table 1. Recommended assessment of the patient with Parkinson’s disease(Mason et al. 1996) 
population (Kao et al. 1994; Sato et al. 1997; Fink et al. 2005; Sato et al. 2005). Patients with 
Parkinson’s disease tend to be less active than patients without the disease, and lack of 
sunlight absorption makes these patients more likely to be ostopenic. Rigidity and 
bradykinesia result in reduction in spontaneous movements, rendering the patient less 
mobile and active. Lack of mobilization stimulates bone calcium resorption, secondary to 
disuse and lack of weight bearing (Clouston et al. 1987; Gross et al. 1995; Inoue 2010).   
Patients with Parkinson’s disease with low BMD are have twice as much the risk of fractures 
when compared with osteoporotic patients without the disease(Taylor et al. 2004).  
Those with poor bone quality are at an increased are at increased risk of intraoperative 
fracture during joint arthroplasty particularly during femoral stem insertion in uncemented 
THA when hoop stresses are at their greatest (Hernigou et al. 2006). In an experimental in 
vitro study Thomsen et al found that patients with poor bone quality treated with 
uncemented THA are at higher risk of periprosthetic fracture and recommended that 
cemented stems should be used in this group of patients(Thomsen et al. 2008).  Improving 
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the patient bone density or preventing continuing bone loss is therefore important before 
joint arthroplasty is considered in patient with PD.  
All patients with Parkinson’s disease referred for orthopaedic assessment for possible joint 
arthroplasty should be screened for osteoporosis and treated appropriately. 
Bisphosphonates are known to reduce osteoclastic activity and immobilization induced 
bone loss has been successfully treated with these agents (Yates et al. 1984; Sato et al. 2007). 
In a randomized control trial in patients undergoing cemented TKA, Hilding et al. showed 
that daily treatment with 400mg of clodronate reduced tibial component migration by 25% 
when compared with placebo at 6 months following surgery(Hilding et al. 2000). Friedl et al. 
have identified reduced migration of cementless acetabular cups in THA over 2 years 
following a single dose of intravenous zoledronate in patients undergoing THA for 
avascular necrosis(Friedl et al. 2009). However, other authors have found the effect of 
bisphosphonates less promising with no beneficial effect of systemic bisphosphonates seen 
over 2 years after hybrid THA and cementless TKA(Wilkinson et al. 2005; Hansson et al. 
2009).  
Patients with PD are also reported to have abnormal bone metabolism(Sato et al. 2005) 
resulting from reduced parathyroid hormone. Recent studies using teriparatide, a 
recombinant human parathyroid hormone, for the treatment of reduced BMD are showing 
promising results (Aspenberg et al. 2010; Ma et al. 2011; Moricke et al. 2011) but so far none 
of the studies are related to patients with PD. 
2.1.3 Physiotherapy 
Physiotherapy has proven functional improvements in patients with PD and this needs to be 
considered in the planning for arthroplasty surgery (Formisano et al. 1992). Physiotherapy 
should not be left for the post-operative phase and emerging evidence suggests that it 
should play a greater role prior to surgery than we realize. Prehabilitation is fast growing to 
be a recognized as a potential key element in arthroplasty pathways and this has been 
particularly noted in patients undergoing total knee arthroplasty (Jaggers et al. 2007; Topp 
et al. 2009; Swank et al. 2011). Patients with PD should not be exempt from this more of 
preparation, and given the potential for poor mobility, loss of muscle mass and bone 
mineral density in this cohort, it may be even more prudent to direct these individuals for 
prehabilitation prior to surgery. 
Nocera et al have found that knee extensor strength has a negative correlation with disease 
severity in PD and a positive correlation with dynamic stability (Nocera et al. 2010). Specific 
physical therapy programs for PD have been shown to be effective for mild to moderate 
disease severity(Ebersbach et al. 2010) . Allen et al in a randomized controlled trial setting 
have shown that a prescribed exercise program results in increased muscle strength and a 
reduced fear of falling in those with PD(Allen et al. 2010). While a painful degenerate joint 
can prohibit some prescribed exercises, gains made prior to surgery will be transcribed to 
potential gains made following surgery. 
2.2 Intra – operative management 
According to the literature, regional anaesthesia is preferred to general anaesthesia, 
especially in patients who require continues infusion of levodopa/carbidopa therapy during 
the procedure(Burton et al. 2004). Backus et al have reported a case of post-extubation 
laryngospasm in an un-anaesthetised patient(Backus et al. 1991). General anaesthesia has 
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been shown to contribute to post-operative confusion, which adversely affects patient 
outcomes and prolongs hospital stay (Duffy et al. 1996; Koch et al. 1997; Weber et al. 2002) 
Propofol which is commonly used to induce general anaesthesia may temporarily supress 
the tremor associated with Parkinson’s disease but it has been also shown to exacerbate 
dyskinesia (Anderson et al. 1994; Krauss et al. 1996). Wright et al have suggested that low 
dose ketamine may represent an alternative sedative for use pre-operatively as it reduces 
dyskinesia and controls Parkinsonian tremor(Wright et al. 2009).  
Of the commonly used analgesics during surgery fentanyl and morphine can both result in 
increased muscular rigidity (Klausner et al. 1988; Berg et al. 1999). Alfentanil has been 
reported to have resulted in dystonic reactions(Mets 1991)  
Succinylcholine can result in hyperkalaemia and should be avoided(Muzzi et al. 1989). Non-
depolarizing muscle relaxants are considered safe(Nicholson et al. 2002). 
2.2.1 Peri-articular infiltration  
A number of randomized control studies (Andersen et al. 2007; Toftdahl et al. 2007; 
Andersen et al. 2010) show the effectiveness of intra operative local infiltration analgesia 
(LIA) in the post - operative period. LIA has been used both during TKA and THA with 
equal effectiveness in pain reduction and reduction in analgesic use in the post - operative 
period. In a randomized, double blinded, placebo controlled study, LIA was used in hip 
arthroplasty (Andersen et al. 2007). Patients treated with local infiltration analgesia 
experienced less pain up to two weeks postoperatively and resulted in less joint stiffness 
and better function one week after the procedure(Andersen et al. 2007).  
Multimodal anaesthetic infiltration around the hip joint has been trialled and reports to date 
suggest that this is an efficacious way of controlling post-operative pain whilst reducing 
requirements for rescue analgesia. Busch et al have shown that peri-articular infiltration of a 
multi-modal analgesic regime has a positive effect on subjective pain following THA and 
results in a reduced requirement for rescue opiate use via PCA(Busch et al. 2010). Lee et al 
reported similar results noting that peri-articular infiltration conferred no increased risk for 
the patient in the post-operative setting. Their multi-modal injection consisted of morphine, 
ropivacaine and methylprednisolone. Parvataneni et al reported superior control of post-
operative pain using peri-articular infiltration of bupivacaine, epinephrine, 
methylprednisolone, cefuroxime and morphine(Parvataneni et al. 2007). Use of periarticular 
infiltrations such as these, particularly in hip arthroplasty can minimise subsequent use of 
opiate based analgesics and reduce the risk of adverse events associated with opiate usage. 
Recent studies show that periarticular infiltration at the end of TKA has several advantages 
over other approaches. In a randomized controlled study by Venditoli et al 42 patients who 
underwent TKA were randomized either to receive an intraoperative infiltration with 
ropivacaine followed by an infusion of ropivacaine through 16 gauge catheter on the first 
post-operative day or control group. Narcotic consumption was less in the first 40 hours 
post op with improved pain scores during rest and exercise for the first forty eight hours 
and fewer nausea symptoms during the first five post-operative days than the control 
group(Vendittoli et al. 2006). It is well known that morphine exerts its analgesic effect by 
binding to opioid receptors in the central nervous system and peripherally (Stein et al. 1989).  
In a double blinded, randomized clinical trial Tanaka et al. have shown that patient who 
were administered intra-articular morphine and bupivacaine had reduced pain scores, a 
much smaller requirement of systemic analgesia, longer duration between the operation  
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and the first requirement of systemic analgesia and improvement in the range of motion of 
the knee joint at time of discharge(Tanaka et al. 2001). Andersen et al. have used a 
combination intraoperative infiltration of ropivacaine ketorolac and epinephrine combined 
with and intra-articular infusion of ropivacaine and ketorolac for the first 48 hours post 
operatively. They found out that peri and intra-articular analgesia with multi modal drugs 
provided superior pain relief and reduced opioid consumption compared with continuous 
epidural infusion with ropivacaine combined with intravenous ketorolac(Andersen et al. 
2010). These protocols can be used in patients with Parkinson’s disease to help reduce the 
use of opioids in the post-operative period and reducing the risk of multi drug interaction 
and side effects. Further studies are required, to assess the effectiveness of these protocols in 
patients with Parkinson’s disease. 
2.3 Post – operative management 
2.3.1 Analgesic management 
In joint arthroplasty, pain control after the procedure is one of the major elements in early 
mobilizations. Most patients are managed with opioid analgesics for the first 24 hours after 
surgery including the use of patient controlled analgesia (PCA). Opioid analgesics are well 
known to cause confusion especially in elderly patients.  
This type of analgesics effect patients’ mental state and can exacerbate Parkinsonian 
symptoms through the dopaminergic pathway (Chudler et al. 1995; Burton et al. 2004). 
Opioid analgesic has also been shown to increase the length of stay in hospital in a 
nationwide study done in Denmark(Husted et al. 2010).  
Multimodal analgesia with non-steroidal anti-inflammatory drugs in patients with adequate 
renal function is reported to be as effective as opioid analgesia with fewer side effects 
(O'Hara et al. 1997; Post et al. 2010). When using multimodal analgesia, it is especially 
important to take early advice from the patient’s neurologist for potential adverse 
interaction between the type of analgesic protocol used and the neurological medication 
regime. 
2.3.2 Respiratory function 
Post-operative nursing care and rehabilitation are an important factor in patients with 
Parkinson’s disease because these patients are at high risk of for falls and fractures (Melton 
et al. 2006; Camicioli et al. 2010). Close attention to the respiratory status in this patient 
cohort following surgery is mandatory. As eluded to earlier, Parkinson’s Disease is 
associated with an obstructive respiratory pattern. This is likely due to the incoordination of 
the upper airway seen in extra-pyramidal disorders(Vincken et al. 1984). Musculature 
around the larynx is likely to be affected by the neuromuscular abnormalities in Parkinson’s 
disease. Patients are therefore prone to atelectasis, retained secretions and respiratory tract 
infections(Easdown et al. 1995). It has been noted that aspiration pneumonia is a not 
infrequent cause of death(Hughes et al. 1993). Pulmonary physiotherapy and early 
commencement of ambulation are essential components to help minimise the risk of these 
complications.  
2.3.3 Physiotherapy 
Patients with Parkinson’s disease require more intensive monitoring than patients without 
the disease in order to prevent complications such as pressure sores. Earlier mobilization 
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and physiotherapy regimes improve motor function, respiratory function and may help in 
preventing muscle contractures (Gobbi et al. 2009; Dereli et al. 2010). The Royal Dutch 
Society for Physical Therapy (KNGF) has published evidenced based clinical practice 
guidelines in order to be able to deliver optimal care to patients with PD. These guidelines 
have been also adopted by the Association of Physiotherapist in Parkinson’s disease 
Europe(Keus et al. 2007). The two treatment strategies recommended in these guidelines are 
cognitive movement strategies and cueing strategies. These guidelines also emphasize on 
training joint mobility and training strength which are essential in both the pre- and post-
operative period. Hurwitz et al. showed that an exercise program focused on improving 
joint mobility, in combination with improving mobility and self-care also improved 
memory(Hurwitz 1989). In a randomized control trail, Schenkman et al. showed that an 
exercise program focused at improving joint mobility and coordinated moving incorporated 
in activities of daily living (ADL) improves functional axial rotation and reach(Schenkman 
et al. 1998). Exercise programs which are, focused on improving muscle strength, may also 
improve muscle strength in patients with PD (Toole et al. 2000; Hirsch et al. 2003).  
Again, in the post-operative phase it is important to remain cognizant of the potential 
pharmacological interactions that may precipitate orthostatic hypotension and lead to a 
reduced mobility or increased risk of falling. 
3. Parkinson’s disease and arthroplasty 
There is limited literature focusing on joint arthroplasty in patients with Parkinson’s disease 
and so far there are only 17 studies. Seven studies dealt with fractures of the femoral neck 
treated with hemi-arthroplasty(Rothermel and Garcia 1972; Coughlin and Templeton 1980; 
Eventov, Moreno et al. 1983; Staeheli, Frassica et al. 1988; Turcotte, Godin et al. 1990; Clubb, 
Clubb et al. 2006; Kryzak, Sperling et al. 2010), 6 studies dealt with total knee arthroplasty in 
Parkinson’s disease(Oni and Mackenney 1985; Vince, Insall et al. 1989; Fast, Mendelsohn et 
al. 1994; Duffy and Trousdale 1996; Erceg and Maricevic 2000; Shah, Hornyak et al. 2005), 2 
studies dealt with total hip arthroplasty(Weber, Cabanela et al. 2002; Meek, Allan et al. 2006) 
and 2 dealt with total shoulder arthroplasty. In this section we will provide an overview of 
the evidence available for arthroplasty in PD specific to the three major joints replaced – hip, 
knee and shoulder. 
3.1 Hip 
3.1.1 Hemiarthroplasty for femoral neck fractures 
The 7 studies (Rothermel et al. 1972; Coughlin et al. 1980; Eventov et al. 1983; Staeheli et al. 
1988; Turcotte et al. 1990; Clubb et al. 2006; Kryzak et al. 2010), that discussed the outcome of 
hemi-arthroplasty in Parkinson’s disease are not strictly applicable since the procedure is 
usually undertaken as an emergency or semi-elective procedure, but some inferences can be 
taken in terms of rates of dislocation and post-operative complications(Table.2. Page 516). 
However, it must be remembered that the biomechanics of a hemiarthroplasty are different 
to those in THA. 
Turcotte, et al(Turcotte et al. 1990) reported that out of 41 patients undergoing 47 hemi-
arthroplasty for a Garden III – IV fracture , five subsequently dislocated and four of these 
within the first month of surgery. Four patients had wound infections, one subsidence of the 
stem, one acetabular protrusion, one femoral shaft fracture, three decubitus ulcers on the 
operated limb and one patient died within the first 6 months. Four patients never walked  
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Study 
authors 
Study type
Arthroplasty 
(type + 
numbers) 
Mean age 
(yrs, 
range) 
Length of 
follow up 
(yrs) 
Implant type/surgical 
technique 
Outcome 
Weber et 
al 
retrospective THR(107) 
72 (57 - 
87) 
7.1 (2 - 21)
94 acetabular cups and 
103 femoral stems 
were cemented, 13 
acetabular cups and 4 
stems were 
uncemented 
93% pain free, 6% 
dislocations, 3% aseptic 
loosening, 26% post 
oprative medical 
complication rate 
Meek et 
al 
retrospective THR(2394) N/A N/A N/A 
0.46 annual dislocation 
rate 
Kryzak et 
al 
retrospective
Hemi 
hip 
 0.5 - 6 years
posterior approach, 
various types of endo 
prosthesis 
6 month mortality 75%, 
37% dislocation, 8.3% 
deep wound infection 
Clubb et 
al 
Literature 
review 
Hemi  
hip 
N/A N/A N/A N/A 
Eventov 
et al 
retrospective
Hemi  
hip (62) 
74 ( 61 - 
90) 
N/A 
34 patients had a 
hemiarthroplasty using 
the posterolateral 
approach, 11 
underwent plate and 
nail fixation , the rest 
were treated non 
operativly 
31% mortality at 3 
months, pneumonia most 
frequent cause of dead, 
complications highest in 
the operated group. 
Rothermel 
et al 
retrospective
Hemi  
hip (16) 
63.5 N/A 
7 treated with 
hemiarthroplasty, 3 
McLaughlin nail, plate 
and screws, 1 miltiple 
pins 2 nail and plate 
and 2 on traction 
12.5% flexion 
contractures, 
Coughlin 
et al 
retrospective
Hemi  
hip (13) 
78 0.5 - 6 years
posterior approach, 
various types of endo 
prosthesis 
6 month mortality 75%, 
37% dislocation, 8.3% 
deep wound infection 
Staeheli 
et al 
retrospective
Hemi  
hip (50) 
74.3 (47 - 
92) 
7.3 years 
50% anterolateral 
approach, 40% 
posterior approach and 
10 % trans trochanteric 
approach, various 
prosthesis used 
2% dislocation, 20% 
mortality at 6 months, 
pneumonia was the most 
frequent cause of dead 
Turcotte 
et al 
retrospective
Hemi  
hip (47) 
74 (51 - 
89) 
N/A posterior approach 
8.5% wound infection, 
11% dislocated, , 2.1% 
subsidence, 2.1% 
protrusio acetabuli, 2.1% 
femoral shaft fracture, 
6.4% decubitus ulcers, 
15% mortality at 6 
months 
Table 2. Summary of the studies in patient with Parkinson’s disease undergoing THR or 
Hemiarthroplasty. 
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again despite being ambulatory prior to surgery. Overall mortality in these patients was 
15%(Turcotte et al. 1990) mainly due to increased medical complications.  
Other studies had better outcomes with Staeheli et al(Staeheli et al. 1988) reporting only one 
dislocation out of a series of 49 patients undergoing hemi-arthroplasty for femoral neck 
fracture, while Eventov et al have reported a 3% dislocation rate (Eventov et al. 1983).  
Some studies have reported mortality rates as high 47% within the first 6 months after hemi-
arthroplasty of the hip(Coughlin et al. 1980). As in other studies the high mortality rate was 
mainly due to increased medical complications including myocardial infarction, urosepsis 
and pneumonia (Staeheli et al. 1988; Turcotte et al. 1990). Aggressive physiotherapy and 
early mobilization was advised for patients with Parkinson’s disease undergoing hemi-
arthroplasty(Coughlin et al. 1980; Eventov et al. 1983; Staeheli et al. 1988; Turcotte et al. 
1990). Some of these studies have also advised that patients with Parkinson’s disease should 
be treated with internal fixation of the fracture and that hemi-arthroplasty may be 
contraindicated (Coughlin et al. 1980; Turcotte et al. 1990). 
3.1.2 Total hip arthroplasty 
Total Hip Arthroplasty (THA) is usually performed in patients with osteoarthritis (OA) 
(Fig.1. Page 518 & Fig.2. Page 519) to relieve pain and improve joint function. In a review of 
total hip arthroplasty (THA) in patient with neurological conditions , Queally et al found 
only two studies in the literature which report the results of THA in patients with 
Parkinson’s disease(Queally et al. 2009). These studies reported lower rates of dislocation 
than those noted in reported cohorts of hemiarthroplasty in the trauma setting. Meek et al 
have reported only two dislocations in 1467 patients with Parkinson’s disease who 
underwent THA between 1996 and 2004 as reported in the Scottish National Arthroplasty 
Registry(Meek et al. 2006). They also found an annual incidence of Parkinson’s disease 5% to 
8% in patients undergoing THA (Meek et al. 2006).  
Weber et al reported a high rate of post-operative complications (26%) in 98 patients with 
Parkinson’s disease after THA at mean follow up at 7.1 years(Weber et al. 2002). An 
anterolateral approach was used in 56 patients, trans-trochanteric in 36, postero-lateral in 12, 
and direct lateral in three patients. No dislocations or wound infections were noted. They did 
note that THA provided a high level of long lasting pain relief and initial improvement in 
ambulation. Functional decline in the individuals was related to the neurological disease and 
was not joint specific. There were 6 dislocations in the revision THA group, which included 1 
from the trans-trochanteric approach, 1 from the direct lateral and 4 from the anterolateral 
approach. The low rate of dislocation seen in these 2 studies is mostly related to both 
advancement in medical management of Parkinson’s disease developed in recent years and 
the wider choice of biomaterials such as constrained liners and larger femoral heads which 
improve stability at the hip joint. These 2 studies are summarised in Table. 2 (page 516). 
General decline in mobility in Parkinson’s disease can lead to weakness in abductor muscle 
function. Application of biomechanical principles suggests that increasing the offset can 
optimize abductor function by lengthening the abductor lever arm. Contractures may 
develop in any individual after hip arthroplasty, limiting functional gains. This potential 
case is probably more likely in PD due to the lower mobility and associated problems with 
rigidity. Bhave et al have found that administration of botulinum toxin to the contracted 
muscle groups can help alleviate this problem. Injection to a variety of muscle group 
including the adductors, abductors and hip flexors resulted in lasting improvement in range 
of movement for 20 months or more(Bhave et al. 2009). 
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Fig. 1. Anteroposterior radiograph of the pelvis showing, right hip osteoarthritis with a triad 
of joint space narrowing, subchondral cysts and osteophyte formation. 
3.2 Knee 
3.2.1 Knee Arthroplasty 
Total Knee Arthroplasty (TKA) has been condemned for patients with Parkinson’s disease 
by Oni et al in 1985 when they reported 3 cases of TKA complicated by a persistent flexion 
contracture of the hamstrings induced by the operation itself(Oni et al. 1985). Quadriceps 
tendon rupture was also seen in two patients. All three patients died within six months of 
surgery.  
Vince et al reported 13 TKA in 9 patients with Parkinson’s disease at time of surgery(Vince 
et al. 1989). All knees showed fixed flexion before the arthroplasty. Ten joints had a posterior 
stabilised implant; one revision joint arthroplasty required a customized stem implant and 
the other two cases underwent a total condylar I and II. Nine of 12 primary knee 
replacement achieved excellent scores Hospital for Special Surgery knee rating system 
within the first year and the other 3 had good scores. Even though complications such as 
urinary tract infections, deep vein thrombosis and pulmonary embolism were common, all 
patients recovered. The authors’ advice that with careful consideration of age and severity 
of disease TKA; may improve the function of patients with Parkinson’s disease by 
alleviating the pain, correcting flexion deformity and restoring movement. 
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Fig. 2. Anteroposterior radiograph of the pelvis showing a right Hybrid (cemented 
stem/uncemented acetabular cup)THA and osteoarthritic left hip joint. 
Duffy et al reported results from a retrospective review of 24 patients (33 knees) with 
Parkinson’s disease who underwent TKA with patellar resurfacing(Duffy et al. 1996). All 
patients in this study continued levodopa/carbidopa up to the day of surgery and restarted 
it within 24 hours of surgery. Knee scores were assessed according to the Knee Society 
system at 2 months one year and mean follow up of 2.8 (2.2 - 6) years. Pain scores as 
determined by The Knee society scoring system, improved from a mean of 34 points before 
surgery to 89 points at the last follow up. On the other hand functional scores did not 
improve that much with 42 points pre – operatively to 68 points post operatively. Poor 
functional scores where reported due to progression of Parkinson’s disease with increased 
imbalance, decreased muscle control, and increased rigidity(Duffy et al. 1996). In view of 
this the authors agree with Vince et al and recommend TKA in reliving the pain of arthritic 
knees in patient with Parkinson’s disease(Vince et al. 1989; Duffy et al. 1996).  
Two case reports have highlighted potential problems following TKR (Erceg et al. 2000; 
Shah et al. 2005). Erceg et al reported a case of recurrent dislocation with a posterior 
www.intechopen.com
 
Diagnostics and Rehabilitation of Parkinson's Disease 520 
stabilized TKA in a patient with Parkinson’s disease(Erceg et al. 2000). According to the 
authors, the recurrent posterior dislocation was mainly due to destruction of the cam of the 
polyethylene tibial insert caused by entrapped cement rather than progression of Parkinson’s 
disease. Flexion contracture seems to be one of the most common complications after TKA in 
patients with Parkinson’s disease (Oni et al. 1985; Duffy et al. 1996; Shah et al. 2005).  
Shah et al describe a case which was effectively managed with a manipulation under 
anaesthesia and motor point blocks of the long head of the biceps femoris and 
semitendinosus with botulinum toxin type A(Shah et al. 2005).  The authors recommend that 
motor block injection with Botulinum toxin type A may be a viable alternative to open 
hamstring release in treating flexion contractures in patients with Parkinson’s disease(Shah 
et al. 2005). A summary of these papers is shown in Table. 3 (page 520). 
 
Study 
authors 
Study type
Arthroplasty 
(type + 
numbers) 
Mean 
age (yrs, 
range) 
Length of 
follow up 
(yrs) 
Implant type/surgical 
technique 
Outcome 
Oni et al case series TKR(3) 
76(72 - 
83) 
2 
1 Stanmore , 2 Oxford 
meniscal TKA 
Flexion 
contracture(3), quads 
rupture (2), death in 
2 years(3) 
Shah et al case series TKR(1) 61 6.5 months N/A Flexion contracture 
Vince et al retrospective TKR(13) 
70(64 - 
75) 
4.3(1-8) 
Condylar type 
resurfacing 
arthroplasty, posterior 
stabilised TKA(10), 
Custom prosthetic (1), 
Total conylar I(1), total 
condoylar II(1), all 
cemented and all 
patella resurfaced 
flexion contracture 
(5), patellar fracture 
1, patellar 
subluxation(1), 
DVT(4), PE(2) 
Erceg et al case series TKR(1) 65 1 PFC 
Recurrent posterior 
tibial dislocation 
Duffy et al retrospective TKR(33) 71 2.8(2.2 - 6)
cemented condylar 
TKA of a single design 
(press-fit condylar), 
Johnson & Johnson. 
patellar subluxation 
(2), deep vein 
thrombosis (2), 
superficial infection 
(2), myositis 
ossificans (1), 
reoperation (4), 
patellar fracture (2), 
deep wound 
infection(2) 
Table 3. Summary of the studies in patient with Parkinson’s disease undergoing TKR. 
Macauley et al have suggested a list of contraindications for total knee arthroplasty. These 
include any level of preoperative delirium, any contraindication to regional anaesthesia, re-
operative fixed flexion deformity of greater than 25 degrees, a lack of a multidisciplinary 
team, and a Hoehn and Yahr rating greater than, or equal to, 3 (Table. 4. page 521)(Hoehn et 
al. 1967). They also propose that failure to respond to a diagnostic intra-articular infiltration 
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of bupivacaine as a contraindication(Macaulay et al. 2010). Specific pre-operative planning 
should include appropriate implant selection. Cruciate retaining rather than cruciate 
substituting prostheses should be used. In severe disease constrained knees or hinged 
prostheses should be considered. The need for these considerations has been highlighted by 
the reports of dislocated prostheses (Macauley et al, 2010).  
Femoral nerve blockade is contraindicated following knee arthroplasty – early quadriceps 
motor block could predispose to early development of a knee flexion deformity. Continuous 
Passive Motion (CPM) is not recommended as this can exacerbate the rigidity experienced. 
3.3 Shoulder 
3.3.1 Shoulder hemiarthroplasty for proximal humeral fractures 
One report has assessed the outcomes of shoulder hemiarthroplasty for proximal humerus 
fractures (Kryzak et al. 2010). Their retrospective review of seven patients with a minimum 
of two years follow-up suggested that the surgical outcomes for patients with Parkinson’s 
disease are poor. Mean achievable abduction was 97 degrees, external rotation 38 degrees 
and internal rotation to the level of the sacrum. Although there was one non-union and one 
mal-union no patient required revision surgery. On a scale of 1-5 the mean pain score 
remained as high as 2.5 and the authors concluded that the benefit of this surgical procedure 
in patients with Parkinson’s disease is marginal. Consequently patients need to be 
counselled regarding the poor prognosis in surgery with anticipated persistent pain and 
restriction of movement. 
 
Stage 1 Not disabling, mild, unilateral symptoms (e.g. tremor, posture, locomotion, and 
facial expression). 
Stage 2 Bilateral involvement, without impairment of balance. Possibly already a light 
kyphotic posture, slowness and speech problems. Postural reflexes are still intact. 
Stage 3 Significant slowing of body movements, moderate to severe symptoms, postural 
instability, walking is impaired, but still possible without help, physically 
independent in ADL 
Stage 4 Severe symptoms, rigidity and bradykinesia, partly disabled, walking is 
impaired, but still possible without 
Stage 5 Fully disabled, walking and standing impossible without help, continuous 
nursing care is necessary 
Table 4. The Hoehn and Yahr scale for staging Parkinson’s disease (Hoehn et al. 1967). 
3.3.2 Total shoulder arthroplasty 
There are two studies reviewing patients with Parkinson’s disease that underwent a total 
shoulder arthroplasty (TSA)(Koch et al. 1997; Kryzak et al. 2009)(Table 5. Page 522).  
The first study by Koch et al, reviewed 15 patients between 1979 and 1990 who underwent 
TSA in the Mayo clinic, Rochester(Koch et al. 1997). There were 16 TSA performed in 15 
patients suffering from Parkinson’s disease that were prospectively monitored as part of the 
total shoulder arthroplasty registry with average length of follow up of 5.3 years. Six of the 
patients in the study group were deceased at the most recent review and the average follow 
up was 2.1 years. The authors report that only 25% of the group achieved excellent results, 
12.5% were rated satisfactory and 62.5% rated unsatisfactory. They also reported a 
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significant reduction in external rotation after surgery. Three patients out of 15 required 
revision surgery, two for painful subluxation and one for glenoid loosening. The authors 
concluded that despite careful rehabilitation and medical management of Parkinson’s 
disease, functional results are poor, particularly in patients older than 65 years of age.  
Recently Kryzak et al have reported a series of 49 TSA performed in patients with 
Parkinson’s disease for osteoarthritis of the shoulder(Kryzak et al. 2009). Mean age of 
patients at time of surgery was 69.7 years and 17 TSA were done in women while 32 were in 
men. Mean age of follow up was 8 years. Eight out of 49 shoulders were revised, three were 
revised in less than one year due to instability, four were revised due to loosening of the 
components and one due to periprosthetic fracture(Kryzak et al. 2009). The authors report a 
significant relief of pain with the average pain score decreasing from 4.6 pre-op to 1.8 post-
op at last follow up. Overall they had 10 excellent (23%) results, 13 satisfactory (30%) results 
and 20 unsatisfactory (47%) results. The most common reason for unsatisfactory results 
were insufficient abduction, external rotation or a combination of both, instability requiring 
revision and continued pain. 
 
Study 
authors 
Study type 
Arthroplasty 
(type + 
numbers) 
Mean 
age (yrs, 
range) 
Length of 
follow up 
(yrs) 
Implant type/surgical 
technique 
Outcome 
Kryzak et 
al 
retrospective TSA (49) 
69.7 (54 
- 87) 
8 years 
31 Cofield (Smith and 
Nephew, Memphis, TN), 
13Neer (Kirschner 
Medical, Fairlawn, NJ), 4 
Tornier 
(Grenoble,France), and 1 
Biomet humeral 
components (Warsaw, 
IN), 26 Cofield (Smith 
and Nephew), 18 Neer 
(KirschnerMedical), 4 
Tornier (Grenoble, 
France), and 1 Biomet 
glenoidcomponents 
(Warsaw, IN) 
16.3% of 
shoulders 
revised, 88% 
survival free of 
revision, 23% had 
excellent results, 
30% satisfactory 
and 47% 
unsatisfactory 
Koch et al retrospective TSA (16) 
49 - 84 
years 
5.3 (1.2 - 
15) years 
standard deltopectoral 
approach was used, 12 
cases used Neer 
(Kirschner Medical, 
Fairlawn, NJ), 4 cases 
treated with Cofield 
(Smith and Nephew, 
Memphis, TN) 
40% of patient 
were dead at the 
most recent 
review, 25% rated 
as excellent, 
12.5% rated as 
satisfactory and 
62.5% rated as 
unsatisfactory 
results. 3 patients 
required revision 
2 for subluxation 
and 1 for aseptic 
loosening 
Table 5. Summary of the studies in patient with Parkinson’s disease undergoing TKR. 
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4. Summary 
Parkinson’s disease affects a not inconsiderable proportion of the population and it is 
inevitable that the orthopaedic surgeon encounters these patients in practice. Arthroplasty 
of the hip, knee and shoulder are frequently used to alleviate pain from numerous 
arthropathies and hip and shoulder arthroplasty utilized in selected fracture patterns 
around the respective joints. 
We have highlighted specific areas that require attention in the pre-, intra-, and post-
operative management of patient with Parkinson’s disease undergoing arthroplasty 
procedures. Although outcomes following elective arthroplasty procedures are promising, 
outcomes after shoulder hemiarthroplasty for trauma are less than encouraging.  
Despite this, there is a distinct lack of evidence in the literature for many facets of care. We 
encourage physicians and surgeons alike to optimise the medical and surgical management 
of patients with Parkinson’s disease to ensure best possible outcomes. 
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